small cell lung cancer patients who failed primary systemic therapy or who failed after response were randomly assigned to salvage treatment with etoposide ( vp-16 ) and cisplatin ( cddp ) or bis-chloro-ethylnitrosourea , thiotepa , vincristine , and cyclophosphamide ( btoc ) .
C0010583
cyclophosphamide
C0279415
btoc